Technology Focus: Digital Tool for Amblyopia Care

Optometrists share how perceptual learning software enhances patient outcomes while expanding in-practice care options.

By: Julie Greenbaum, editor

Optometric Management April 1, 2026

Clinical Report: Digital Tool for Amblyopia Care

Overview

RevitalVision, an FDA-cleared perceptual learning software, enhances amblyopia treatment by leveraging neuroplasticity to improve specific aspects of visual acuity and patient confidence, particularly in activities like driving. Optometrists report significant patient outcomes, including enhanced driving capabilities and overall quality of life.

Background

Amblyopia, commonly known as lazy eye, is a leading cause of visual impairment in children and can persist into adulthood if untreated. Traditional therapies often involve patching or corrective lenses, which can be time-consuming and may not engage patients effectively. Advancements in digital therapeutic tools like RevitalVision offer new avenues for treatment, enhancing patient engagement and providing optometrists with innovative methods to address visual deficits effectively.

Data Highlights

No numerical data provided in the source material, but qualitative findings indicate improved patient experiences and outcomes.

Key Findings

RevitalVision improves specific aspects of visual acuity, contrast sensitivity, and stereoacuity in amblyopia patients.
Patients can perform training sessions at home, enhancing accessibility and convenience.
Optometrists report significant improvements in patients' confidence and quality of life, particularly regarding driving.
The software utilizes the brain's neuroplasticity to facilitate visual processing improvements.
RevitalVision is a cash-pay therapy, allowing practices to offer it without insurance constraints.

Clinical Implications

Optometrists can integrate RevitalVision into their practices to provide effective amblyopia treatment, especially for patients who have not responded to traditional therapies. The ability to offer home-based training can enhance patient compliance and outcomes, particularly for those with limited access to in-office therapies.

Conclusion

RevitalVision represents a significant advancement in amblyopia care, providing optometrists with a valuable tool to improve patient outcomes and expand treatment options, while also considering potential limitations such as the need for patient motivation and adherence.

PentaVision

Optometric Management